{"id":"55a81e13-fb85-4bd8-8951-c16d2bd50eff","name":"Vitestro","slug":"vitestro","description":"Dutch medical-robotics company; maker of Aletta, billed as the [World](/companies/world-labs)'s first autonomous robotic phlebotomy device, combining AI, ultrasound imaging, and robotics to locate veins and draw blood, with ~94.5% first-stick success and EU MDR approval. Private.","status":"active","founded":0,"hq":"Nieuwegein, Netherlands","hqLat":52.0298704,"hqLng":5.0929334,"hqGeocodedAt":"2026-08-05T14:54:00.053Z","hqAddress":null,"hqPrecision":null,"website":"vitestro.com","fundingTotal":"70000000","type":"hardware","roles":["robot_maker","robot_operator"],"reviewStatus":"reviewed","heatIndex":75,"lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://vitestro.com/aletta/","title":"Vitestro Aletta phlebotomy robot"},{"url":"https://vitestro.com/news/vitestro-receives-fda-de-novo-authorization-for-aletta/","title":"Vitestro Receives FDA De Novo Authorization for Aletta","sourceName":"Vitestro"},{"url":"https://www.instagram.com/reel/Dd4S8z6gytB/","title":"Vitestro Aletta drawing blood from real patients; NIR/ultrasound/Doppler (uncover.robotics via Instagram)","sourceName":"Instagram (@uncover.robotics / via Deploy.Report digest)","publishedAt":"2026-09-29"}],"keyFacts":[{"label":"Robot","value":"Aletta, an autonomous robotic phlebotomy device"},{"label":"Technology","value":"Combines AI, ultrasound imaging, and robotics to locate veins and draw blood"},{"label":"Performance","value":"~94.5% first-stick success rate"},{"label":"Stage","value":"Received EU MDR approval"},{"label":"Focus","value":"Medical robotics"},{"label":"FDA De Novo Aletta (primary Vitestro)","value":"Vitestro's Aug 20 2026 release says the FDA granted De Novo authorization for Aletta, its Autonomous Robotic Phlebotomy Device (ARPD). Vitestro frames this as the first U.S. regulatory clearance for a fully autonomous blood draw system and a new device classification. CEO Toon Overbeeke is quoted on CE mark in Europe and the U.S. authorization. Treat 'first'/'world's first' wording as company-stated ([Vitestro](https://vitestro.com/news/vitestro-receives-fda-de-novo-authorization-for-aletta/))","sourceUrl":"https://vitestro.com/news/vitestro-receives-fda-de-novo-authorization-for-aletta/"},{"label":"Imaging US trial plans (primary Vitestro)","value":"The same Vitestro release says Aletta combines multimodal imaging (near-infrared, ultrasound, and Doppler ultrasound) with robotics and AI to identify veins, guide needle insertion, and collect samples. It says Aletta is already CE-marked and in clinical and pre-commercial use in Europe, and that Vitestro plans a U.S. multicenter clinical trial before U.S. commercial availability, with Europe commercial deployment first ([Vitestro](https://vitestro.com/news/vitestro-receives-fda-de-novo-authorization-for-aletta/))","sourceUrl":"https://vitestro.com/news/vitestro-receives-fda-de-novo-authorization-for-aletta/"}],"aliases":[],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":null,"stockExchange":null,"secCik":null,"revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-06-24T05:33:59.935Z","updatedAt":"2026-09-30T14:56:43.547Z","jsonLd":{"@context":"https://schema.org","@type":"Organization","@id":"https://registry.deploy.report/companies/vitestro","url":"https://registry.deploy.report/companies/vitestro","name":"Vitestro","description":"Dutch medical-robotics company; maker of Aletta, billed as the [World](/companies/world-labs)'s first autonomous robotic phlebotomy device, combining AI, ultrasound imaging, and robotics to locate veins and draw blood, with ~94.5% first-stick success and EU MDR approval. Private.","identifier":"55a81e13-fb85-4bd8-8951-c16d2bd50eff","address":"Nieuwegein, Netherlands","publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"verified","maturity_stage":null,"lifecycle_state":null,"architectural_position":{"cohort":null,"sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":3,"primary_source_types":[]}}}